OXB-103

N/A

Report date: 2025/01/26 15:40:57

Base Information

Drug NameOXB-103
Drug Alias NameVEGF gene therapy (Oxford BioMedica)MoNuDinVEGF gene therapy(Oxford BioMedica)OXB-103
ClassificationBiologics
Mechanisms of ActionVascular endothelial growth factor gene transference
TargetsVascular endothelial growth factor
Therapy Area/IndicationsAmyotrophic Lateral Sclerosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited Kingdom
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesOxford Biomedica PLC
China Registration ClassN/A

Develop Information

Active CompaniesOxford Biomedica PLC
Inactive CompaniesN/A
Active IndicationsAmyotrophic Lateral Sclerosis
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A